Haj Najeeb, Bilal
Deak, Gabor G.
Sacu, Stefan
Schmidt-Erfurth, Ursula
Gerendas, Bianca S. http://orcid.org/0000-0001-8940-8130
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 9 April 2021
Revised: 23 June 2021
Accepted: 16 July 2021
First Online: 26 August 2021
Declarations
:
: Ethical approval was obtained from the institution’s review board of each participating center for the inclusion into the multicenter core trials and from the Ethics Committee of the Medical University of Vienna for this retrospective analysis of the prospective studies.
: BHN: RetInSight, unrelated to this study. GD: none. SS: Roche, Novartis, and Bayer, all unrelated to this study, USE: Bayer/Novartis/Boehringer-Ingelheim/Alcon/Kinarus, RetInSight, all unrelated to this study. BG: Novartis/Kinarus/IDx, all unrelated to this study.